Gilbert J Thomas-Black Micheal H Parkinson Fion Bremner Paola Giunti; Brain, awz117, doi:10.1093/brain/awz117
The results from this study show that OCT measurements of RNFL thickness have the potential to become a robust and objective biomarker for future treatment trials in FRDA.
Subscribe to:
Posts (Atom)
